Bud BilanichSuccess Coach
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email